References
- LOlbe, LLundell. Aggressive factors I. Hydrochloric acid. In FPBrooks, editor. Peptic ulcer disease. Contemporary issues in gastroenterology. NY: Churchill Livingstone; 1985. p 151–80.
- PBerntsson, ABrändström, UJunggren, LPalmer, SESjöstrand, GSundell. Gastric acid secretion inhibitors II. Carbamates and aromatic alcohols and phenols. Acta Pharm Suec 1977;14:229–36.
- LOlbe. editor. Proton pump inhibitors. Milestones in drug therapy. Basel: Birkhäusers Verlag; 1999.
- CEMalen, BHDanree, XBLPascaud. New thiocarboxamides derivatives with specific gastric antisecretory properties. J Med Chem 1971;14:244–6.
- GSundell, KOBorg, LGarberg, SESjostrand. Effects of H 81/75 on gastric acid secretion in vagally innervated and denervated acute fistula rat preparations. Acta Pharma Tox 1974;35:83.
- PLindeberg, ABrändström, BWallmark, HMattsson, LRikner, KJHoffmann. Omeprazole, the first proton pump inhibitor. Med Res Rev 1990;10:1–54.
- GSundell, SESjöstrand, LOlbe. Gastric antisecretory effects of H 83/69. A benzimidazolyl-pyridyl-methyl-sulphoxide. Acta Pharm Tox 1977:77.
- TBerglindh. Effects of common inhibitors of gastric acid secretion on secretagougue-innduced respiration and aminopurine accumulation in isolated gastric glands. Biochim Biophys Acta 1977;464:217–33.
- TBerglindh, DRDibona, SIto, GSachs. Probes of parietal cell function. Am J Physiol 1980;238:G165–76.
- BWallmark, BMJaresten, HLarsson, BRyberg, ABrändström, EFellenius. Differentiation among inhibitory actions of omeprazole, cimetidine and SCN- on gastric acis secretion. Am J Physiol 1983;245:G64–71.
- JGForte, HCLee. Gastric adenosine triphosphatases: a review of their possible role in HCL secretion. Gastroenterology 1977;73:921–6.
- GSachs, HChang, ERabon, RShackman, HMSarau, GSaccomani. Metabolic and membrane aspects of gastric H+ transport. Gastroenterology 1977;71:931–40.
- EFellenius, TBerglindh, GSachs, LOlbe, BElander, SESjöstrand, et al. Substituted benzimidazoles inbibit gastric acid secretion by blocking (H+K+) ATPase. Nature 1981;290:159–61.
- EFellenius, BElander, BWallmark, UHaglund, HFHelander, LOlbe. A micromethod for the study of secretory function in isolated human oxyntic glands from gastroscopic biopsies. Clin Sci (Lond) 1983;64:423–31.
- RLeth, BElander, UHaglund, LOlbe, EFellenius. Histamine H2 receptors of the human and rabbit gastric parietal cells. Am J Physiol 1987;253:G497–501.
- BElander, EFellenius, RLeth, LOlbe, BWallmark. Inhibitory action of omeprazole on acid formation in gastric glands and on H+, K+-ATPase isolated from human gastric mucosa. Scand J Gastroenterol 1986;21:268–72.
- LOlbe, UHaglund, RLeth, TLind, CCederberg, GEkenved, et al. Effects of substituted benzimidazole (H149/94) on gastric acid secretion in humans. Gastroenterology 1982;83:193–8.
- OBonnevie, AMNielsen, PMatzen, JWandall, FBendtsen, et al. Gastric acid secretion and duodenal ulcer healing during treatment with omeprazole. Scand J Gastroenterol 1984;19:882–4.
- CBLamers, TLind, SMoberg, JBJansen, LOlbe. Omeprazole in Zollinger Ellison syndrome: effects of a single dose and of long-term treatment in patients resistant to histamine H2 receptor antagonists. N Engl J Med 1984;310:758–61.
- DYGraham. Helicobacter pylori; consensus reached: peptic ulcer is on the way to becoming a historical disease. Am J Gastroenterol 1994;89:1137–9.
- NIH Consensus Conference Helicobacter pylori in peptic ulcer disease. NIH Consensus development panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65–9.
- TLind, THavelund, RCarlsson, OAnker-Hansen, HGlise, HHernqvist, et al. Heartburn without esophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997;32:974–9.
- RHHolloway, JDent, FNarielvala, AMMackinnon. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis. Gut 1996;38:649–54.